Abstract
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are increasingly used as add-on therapy in patients with poorly controlled type 2 diabetes mellitus ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
